Clinical Trial Update: Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Captisol-enabled melphalan pharmacokinetics in patients with multiple myeloma or AL amyloidosis undergoing autologous stem cell transpl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Multiple Myeloma

Drugs mentioned

• Captisol-enabled melphalan (melphalan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma, Amyloidosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING